Why should elderly patients avoid diphenhydramine (Benadryl)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Elderly Patients Should Avoid Benadryl (Diphenhydramine)

Elderly patients should not take Benadryl because it significantly increases their risk of delirium, cognitive impairment, falls, and fractures due to its potent anticholinergic effects that disproportionately affect older adults.

Primary Evidence from Guidelines

The 2019 American Geriatrics Society Beers Criteria explicitly identifies diphenhydramine and other first-generation antihistamines as potentially inappropriate medications for older adults 1. While the provided excerpt doesn't detail the specific antihistamine recommendations, the Beers Criteria framework establishes the foundation for avoiding medications with strong anticholinergic properties in this vulnerable population.

Specific Risks in the Elderly

Cognitive Impairment and Delirium

Diphenhydramine causes substantial cognitive decline in elderly patients through its anticholinergic mechanism. Hospitalized older patients receiving diphenhydramine face a 70% increased risk of developing delirium symptoms (RR 1.7), with even higher risks for specific symptoms: 3-fold increased risk of inattention, 5.5-fold increased risk of disorganized speech, and 3-fold increased risk of altered consciousness 2. These effects demonstrate a clear dose-response relationship, meaning higher doses cause progressively worse outcomes.

The cognitive effects are particularly insidious because they may not be immediately obvious on standard performance testing. Neurophysiologic studies reveal that diphenhydramine significantly impairs brain function in elderly individuals even when behavioral performance measures appear only marginally affected 3. This means the drug is damaging cognitive function at a neurological level before it becomes clinically apparent through obvious confusion or disorientation.

Falls and Fractures

First-generation antihistamine use, including diphenhydramine, doubles the risk of injurious falls or fractures in elderly patients (OR 2.03) 4. This meta-analysis provides high-quality evidence that the anticholinergic side effects—including sedation, dizziness, and impaired coordination—translate directly into serious physical injuries. For hospitalized elderly patients, this risk may be even higher (OR 2.89) 4.

Additional Adverse Effects

Beyond cognitive and fall risks, elderly patients taking diphenhydramine experience:

  • Longer hospital stays (median 7 vs 6 days) 2
  • Increased need for urinary catheterization (2.5-fold increased risk), likely due to anticholinergic urinary retention 2
  • Anticholinergic toxidrome including agitation, tachycardia, dilated pupils, and dry skin—which can develop rapidly, even within 20 minutes of administration 5

Why the Elderly Are Particularly Vulnerable

Older adults are physiologically more sensitive to anticholinergic medications due to:

  • Age-related changes in drug metabolism and clearance
  • Reduced cholinergic reserve in the aging brain
  • Higher baseline risk of cognitive impairment
  • Polypharmacy increasing drug-drug interactions
  • Pre-existing conditions (glaucoma, prostate enlargement, chronic bronchitis) that contraindicate anticholinergic use 6

Clinical Pitfalls to Avoid

  1. Over-the-counter availability creates false sense of safety: Despite being available without prescription, diphenhydramine carries significant risks in elderly patients that many clinicians and patients underestimate 7.

  2. Inappropriate prescribing remains common: Studies show 24% of diphenhydramine doses in hospitalized elderly patients are administered inappropriately 2, and emergency department use remains unchanged despite evolving guidelines 8.

  3. Sleep aid misuse: Diphenhydramine use as a sleep aid increased substantially (from 0.4% to 7.6%) in elderly cohorts over time 7. While some recent evidence suggests efficacy for acute insomnia in adults 9, the cognitive impairment risk in elderly patients without dementia makes this practice particularly concerning 7.

  4. Subcutaneous administration as local anesthetic: Using diphenhydramine as an alternative local anesthetic in elderly patients with "caine" allergies can rapidly precipitate anticholinergic delirium 5.

What to Use Instead

For elderly patients requiring antihistamine therapy:

  • Second-generation antihistamines (cetirizine, loratadine, fexofenadine) lack significant anticholinergic effects and do not cross the blood-brain barrier as readily
  • For sleep disturbances, consider non-pharmacologic interventions first, or medications with better safety profiles in the elderly
  • For allergic reactions, second-generation antihistamines provide equivalent efficacy without the cognitive and fall risks

The evidence is unequivocal: diphenhydramine's anticholinergic burden creates unacceptable risks for elderly patients that far outweigh any potential benefits, particularly given safer alternatives exist for virtually all indications.

References

Research

Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018

Research

Hot, blind, and mad: avoidable geriatric anticholinergic delirium.

The American journal of emergency medicine, 2012

Research

Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.